Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enokizumab in mild persistent asthma
NCT00507130Phase 2Completed
- Sponsor
- MedImmune
- Start
- Jul 2007
- Primary completion
- Jul 2008
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of enokizumab in asthma, sponsored by MedImmune. Started Jul 2007; status: completed.
02
Drugs
enokizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00507130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00507130.